Skip to main content

This job has expired

Scientists and Senior Scientists (Organic Chemistry)

Employer
Selvita SA
Location
Poland, Krakow or Poznan
Salary
Competitive
Start date
17 Sep 2020
Closing date
17 Oct 2020

View more

Discipline
R & D , Scientific
Hours
Full Time
Contract Type
Permanent
Experience Level
Experienced (non-manager)

Job Details

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries with offices in Cambridge, UK, Greater Boston Area, San Francisco Bay Area, as well as, Krakow and Poznan, Poland. The company offers drug discovery support at every stage of the early discovery phase up to the preclinical research phase.

Due to constant development, we are seeking Individuals having a solid experience in the fields of organic or medicinal chemistry with a willingness to share and exchange their know-how, by playing a vital role in the projects for biotech and pharma companies from Europe, the USA, and the rest of the world.

 

Scientists and Senior Scientists (Organic Chemistry)

Workplace: (Poland, Krakow or Poznan)

Growing very fast, we are constantly hiring candidates on varying levels of experience to extend our Team. We hire on Scientist and Senior Scientist positions, depending on the knowledge and experiences of the candidate.

All candidates can count on a comprehensive path of professional development with a lot of support from our side. Fresh Graduates can count for additional mentoring support.

 

Main Duties:

  • Planning and modification of synthesis pathways based on literature-patent analysis
  • Conducting organic syntheses (classic techniques, but also modern organic synthesis, photochemistry, microwaves, flow chemistry, enzymatic)
  • Optimization of leading structures in research projects
  • Defining project risks
  • Control of raw material/reagent management in the project
  • Day-to-day regular laboratory work including the set-up of experiments, analyzing data, interpretation, and reporting of the results

Requirements:

  • Completed university studies in the field of organic chemistry or medicinal chemistry (Ph.D. would be an asset)
  • Knowledge in the modern methods of synthetic organic chemistry, preferably in the pharmaceutical industry
  • Publications in scientific journals would be an asset
  • Ability to work in a team and a very good organization of work
  • Good spoken and written English (an official language of Selvita)

What we offer:

  • Training program enabling scientific development: Peer to Peer Academy, scientific lectures, participation in conferences
  • Extensive research facilities and modern laboratories
  • Daily cooperation and know-how exchange with an experienced research team
  • Non-wage benefits: private medical care, Multisport card, co-financing for meals, English and Polish language courses in the company
  • Support in relocation and legalization procedures
  • Possibility to participate in sports activities (football, volleyball) and access to attractive sports infrastructure: gym and sauna in the building
  • Long-term cooperation based on stable employment conditions

Company

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries with offices in Cambridge, UK, Greater Boston Area, San Francisco Bay Area, as well as, Krakow and Poznan, Poland.

The company offers drug discovery support at every stage of the early discovery phase up to the preclinical research phase. Currently Selvita employs over 400 scientists, among which 30% are PhDs, with extensive experience in several areas of life sciences, and offers the following types of projects:

• Contract chemistry services: medicinal chemistry, custom organic synthesis, scale-up and process chemistry, as well as industrial chemistry

• Biology services: cell and molecular biology, ADME and pharmacokinetics, proteomic analyses, analytical chemistry and method validation • Comparative studies of biosimilar products

• Integrated drug discovery projects combining variety of drug discovery processes from in silico drug design, and synthesis of a target-focused library, SAR and ADME-driven lead optimization and toxicity prediction, followed by complex preclinical in vitro development, all tailored to the customer’s needs.

Selvita's laboratories possess the GLP and GMP certification. Drug discovery clients of Selvita include more than fifty large and medium-sized pharmaceutical and biotechnology companies from USA and Europe.

Selvita also develops proprietary research programs primarily in the area of oncology. The company’s most advanced R&D program is SEL24, a Phase I dual PIM/FLT3 kinase inhibitor, recently outlicensed to Menarini Group. Other projects include SEL120, a first-in-class small molecule inhibitor of CDK8 in preclinical studies developed in partnership with The Leukemia and Lymphoma Society, as well as several drug discovery platforms in immunooncology, immunometabolism and cancer metabolism as well as epigenetics performed independently or in collaboration with global pharma and biotech companies.

Several of our R&D programs are developed in collaboration with global pharmaceutical companies including two collaborations with Merck on cancer metabolism, with H3 Biomedicine on kinase inhibitors, with Nodthera on inflammation, as well as SEL24 with Menarini Group and SEL120 in AML with The Leukemia and Lymphoma Society.

Selvita is listed on the Main Market of Warsaw Stock Exchange (WSE:SLV).

Company info
Website
Telephone
539737646
Location
Bobrzynskiego 14, Cracow (Poland)
Cracow
małopolska
30-348
PL

Get job alerts

Create a job alert and receive personalised job recommendations straight to your inbox.

Create alert